pre-ipo
Stage
About
Celcuity develops cellular diagnostic tests that enable personalized medicine by identifying patients likely to respond to targeted therapies, focusing on the PI3K/AKT/mTOR pathway in solid tumor cancers.
Explore Celcuity's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.